Abstract |
A combination of three selected strains of lactobacilli (Lactobacillus brevis [CD2], L. salivarius [FV2], and L. plantarum [FV9]), whose effectiveness in treating bacterial vaginosis in the form of vaginal tablets has been reported recently, prevented sperm lipid peroxidation that was induced in vitro by a ferrous ion promoter, thus preserving sperm motility and viability. This finding suggests the potential of vaginal probiotic lactobacilli for protecting human spermatozoa from radical oxygen species in the presence of vaginal disorders, thereby improving the fertilization potential of the female host.
|
Authors | Arcangelo Barbonetti, Benedetta Cinque, Maria Rosaria Caterina Vassallo, Salvatore Mineo, Sandro Francavilla, Maria Grazia Cifone, Felice Francavilla |
Journal | Fertility and sterility
(Fertil Steril)
Vol. 95
Issue 8
Pg. 2485-8
(Jun 30 2011)
ISSN: 1556-5653 [Electronic] United States |
PMID | 21497805
(Publication Type: Journal Article)
|
Copyright | Copyright © 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved. |
Topics |
- Cell Survival
- Female
- Humans
- Lactobacillus
(growth & development)
- Levilactobacillus brevis
(growth & development)
- Lactobacillus plantarum
(growth & development)
- Lipid Peroxidation
- Male
- Oxidative Stress
- Probiotics
- Sperm Motility
- Spermatozoa
(metabolism, microbiology, pathology)
- Vagina
(microbiology)
- Vaginosis, Bacterial
(microbiology, therapy)
|